1st Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Devices List (PEMDL)

A successful initial collaboration of the DOH Pharamceutical Division – Medical Device Unit spearheaded by Dir. Anna Melissa S. Guerrero, MD, MPH (HTA) and Dr. Constante Caluya III, MBA and their Expert Advisory Committee for medical devices and supplies led by Dr. Ronaldo H. Estacio, together with the Health Technology Assessment Division headed by Ms. Anne Julienne Genuino-Marfori, RPh, MSc and their Health Technology Assessment Council chaired by Dr. Marita V. Tolentino-Reyes.

ASEAN Member States Virtually Assemble in the recent Drug Price Transparency Workshop

The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.

DOH’s 15th Patient Forum Highlights COVID Response, Accessibility of Health Commodities

The Department of Health (DOH) on March 30, 2022 convened patient groups and civil society organizations (CSOs) to discuss updates on the national government’s COVID-19 response, vaccination program rollout, and the ongoing initiatives to provide Filipinos better access to pharmaceutical commodities and healthcare services during the virtual 15th Policy Dialogue on Universal Health Care (UHC) and Access to Medicines with  theme “Gamot Para sa Lahat, Siguruhing Sasapat”.

DOH Announces Full Implementation of Drug Price Caps with Executive Order No. 155

The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.

Standard Information, Education and Communication (IEC) Materials for the Implementation of Maximum Drug Retail Price through Executive Order No. 155 s. 2021

The Executive Order (EO) No. 155, “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines,” which was issued by President Rodrigo R. Duterte on 07 December 2021, subjected 34 drug molecules or 71 drug formulas under price regulation through Maximum Wholesale Price (MWP) and Maximum Retail Price (MRP). The implementation shall begin on 23 March 2022.